Position in ADPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
304,331
+698.2% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $85,530,622 across 8 Diagnostics & Research names. ADPT ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
140,000 | $31,750,600 | |
| 2 | DHR |
Danaher Corp /De/
|
130,000 | $24,762,400 | |
| 3 | BLLN |
BillionToOne, Inc.
|
86,812 | $10,415,703 | |
| 4 | NTRA |
Natera, Inc.
|
34,689 | $9,416,329 | |
| 5 | GH |
Guardant Health, Inc.
|
41,327 | $6,200,289 | |
| 6 | BDSX |
Biodesix Inc
|
108,694 | $2,451,049 | |
| 7 | XGN |
Exagen Inc.
|
114,893 | $534,252 | |
| 8 | ADPT |
Adaptive Biotechnologies Corp
This page
|
304,331 | $0 |
All Filings in ADPT
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 1,217,325 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | — | 152,500 | Shares | Sole | 2026-05-29 | |
| 2025-03-31 | — | 930,972 | Shares | Sole | 2025-08-06 | |
| 2021-12-31 | — | 352,804 | Shares | Sole | 2022-04-13 | |
| 2021-09-30 | — | 352,804 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | — | 352,804 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | — | 352,804 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | — | 904,854 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | — | 830,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | — | 480,000 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | — | 495,000 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||